While American drug companies Merck (MRK) and Pfizer (PFE) aren't doing well (or at least Merck has bounced off its deep lows rather nicely), check out the performance of Denmark's Novo Nordisk A/S (NVO):

Click to Enlarge
Novo Nordisk

The stock is up about $5 a share today to $106. I had to cut off the top part of the chart because it's a logarithmic scale, but you get the idea.

Eddy Elfenbein

About this author:
Become a Contributor Submit an Article

ETFs In Focus

  • Long Ideas

  • Short Ideas

  • Cramer's Picks